pubmed-article:21207352 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21207352 | lifeskim:mentions | umls-concept:C0029921 | lld:lifeskim |
pubmed-article:21207352 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
pubmed-article:21207352 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:21207352 | lifeskim:mentions | umls-concept:C0009079 | lld:lifeskim |
pubmed-article:21207352 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:21207352 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:21207352 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21207352 | pubmed:dateCreated | 2011-3-24 | lld:pubmed |
pubmed-article:21207352 | pubmed:abstractText | The aim of this naturalistic exploratory study was to examine whether blood antipsychotic drug concentrations can predict rehospitalizations in chronically medicated patients. | lld:pubmed |
pubmed-article:21207352 | pubmed:language | eng | lld:pubmed |
pubmed-article:21207352 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21207352 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21207352 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21207352 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21207352 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21207352 | pubmed:month | Mar | lld:pubmed |
pubmed-article:21207352 | pubmed:issn | 1439-0795 | lld:pubmed |
pubmed-article:21207352 | pubmed:author | pubmed-author:KonradAA | lld:pubmed |
pubmed-article:21207352 | pubmed:author | pubmed-author:SilverHH | lld:pubmed |
pubmed-article:21207352 | pubmed:author | pubmed-author:HiemkeCC | lld:pubmed |
pubmed-article:21207352 | pubmed:author | pubmed-author:SchmidtmannII | lld:pubmed |
pubmed-article:21207352 | pubmed:author | pubmed-author:SaglamHH | lld:pubmed |
pubmed-article:21207352 | pubmed:author | pubmed-author:Stieffenhofer... | lld:pubmed |
pubmed-article:21207352 | pubmed:copyrightInfo | © Georg Thieme Verlag KG Stuttgart · New York. | lld:pubmed |
pubmed-article:21207352 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21207352 | pubmed:volume | 44 | lld:pubmed |
pubmed-article:21207352 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21207352 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21207352 | pubmed:pagination | 55-9 | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:meshHeading | pubmed-meshheading:21207352... | lld:pubmed |
pubmed-article:21207352 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21207352 | pubmed:articleTitle | Clozapine plasma level monitoring for prediction of rehospitalization schizophrenic outpatients. | lld:pubmed |
pubmed-article:21207352 | pubmed:affiliation | Department of Psychiatry and Psychotherapy, University Medical Center, Mainz, Germany. | lld:pubmed |
pubmed-article:21207352 | pubmed:publicationType | Journal Article | lld:pubmed |